David Michael Johnson, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 25,692 shares at $66.58 ($1.7M) on 2021-10-04, disclosed to the SEC on 2021-10-04.
Open-market sale of $1.7M ZNTL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.95 | 4,892 | $323K | 18.9% |
| 2 | $65.95 | 4,892 | $323K | 18.9% |
| 3 | $66.58 | 7,904 | $526K | 30.9% |
| 4 | $66.58 | 7,904 | $526K | 30.9% |
| 5 | $67.20 | 100 | $7K | 0.4% |
| Total | $66.34 avg | 25,692 |
| $1.7M |
| 100% |
| Filing → |
| AURA | BUY | 2023-11-09 | $1.1M | — | Filing → |
| AURA | BUY | 2023-10-05 | $225K | — | Filing → |
| AURA | BUY | 2023-01-09 | $21K | — | Filing → |